JP2018527367A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018527367A5 JP2018527367A5 JP2018513579A JP2018513579A JP2018527367A5 JP 2018527367 A5 JP2018527367 A5 JP 2018527367A5 JP 2018513579 A JP2018513579 A JP 2018513579A JP 2018513579 A JP2018513579 A JP 2018513579A JP 2018527367 A5 JP2018527367 A5 JP 2018527367A5
- Authority
- JP
- Japan
- Prior art keywords
- mixture
- formula
- compound
- acid
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 37
- 239000000203 mixture Substances 0.000 claims 36
- 238000000034 method Methods 0.000 claims 30
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 27
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 14
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims 8
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims 8
- 239000002904 solvent Substances 0.000 claims 8
- 239000011877 solvent mixture Substances 0.000 claims 8
- 239000003054 catalyst Substances 0.000 claims 6
- 238000002425 crystallisation Methods 0.000 claims 6
- 230000008025 crystallization Effects 0.000 claims 6
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 claims 4
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- ZKWFSTHEYLJLEL-UHFFFAOYSA-N morpholine-4-carboxamide Chemical compound NC(=O)N1CCOCC1 ZKWFSTHEYLJLEL-UHFFFAOYSA-N 0.000 claims 3
- 239000011833 salt mixture Substances 0.000 claims 3
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 claims 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims 2
- OCQAXYHNMWVLRH-UHFFFAOYSA-N 2,3-dibenzoyl-2,3-dihydroxybutanedioic acid Chemical compound C=1C=CC=CC=1C(=O)C(O)(C(O)=O)C(O)(C(=O)O)C(=O)C1=CC=CC=C1 OCQAXYHNMWVLRH-UHFFFAOYSA-N 0.000 claims 2
- NTOIKDYVJIWVSU-UHFFFAOYSA-N 2,3-dihydroxy-2,3-bis(4-methylbenzoyl)butanedioic acid Chemical compound C1=CC(C)=CC=C1C(=O)C(O)(C(O)=O)C(O)(C(O)=O)C(=O)C1=CC=C(C)C=C1 NTOIKDYVJIWVSU-UHFFFAOYSA-N 0.000 claims 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- LSPHULWDVZXLIL-UHFFFAOYSA-N Camphoric acid Natural products CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 claims 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims 2
- 230000002152 alkylating effect Effects 0.000 claims 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 2
- 230000000843 anti-fungal effect Effects 0.000 claims 2
- 229940121375 antifungal agent Drugs 0.000 claims 2
- 229960005070 ascorbic acid Drugs 0.000 claims 2
- 235000010323 ascorbic acid Nutrition 0.000 claims 2
- 239000011668 ascorbic acid Substances 0.000 claims 2
- LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 claims 2
- 230000008878 coupling Effects 0.000 claims 2
- 238000010168 coupling process Methods 0.000 claims 2
- 238000005859 coupling reaction Methods 0.000 claims 2
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 claims 2
- 235000011090 malic acid Nutrition 0.000 claims 2
- 239000001630 malic acid Substances 0.000 claims 2
- 235000002906 tartaric acid Nutrition 0.000 claims 2
- 239000011975 tartaric acid Substances 0.000 claims 2
- 150000003536 tetrazoles Chemical class 0.000 claims 2
- 238000006254 arylation reaction Methods 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 0 *c1cnc(C(C(c(c(F)c2)ccc2F)=O)(F)F)cc1 Chemical compound *c1cnc(C(C(c(c(F)c2)ccc2F)=O)(F)F)cc1 0.000 description 2
- UDGASIIGNCBLSI-PMERELPUSA-N N#Cc1ccc(COc(cc2)ccc2C#Cc2cnc(C([C@](C[n]3nnnc3)(c(c(F)c3)ccc3F)O)(F)F)cc2)cc1 Chemical compound N#Cc1ccc(COc(cc2)ccc2C#Cc2cnc(C([C@](C[n]3nnnc3)(c(c(F)c3)ccc3F)O)(F)F)cc2)cc1 UDGASIIGNCBLSI-PMERELPUSA-N 0.000 description 2
- LBBHRBLMMYBWEM-VGFJAJBZSA-N N#Cc1ccc(COC(C=C2)=CC=CC2C#Cc2cnc(C([C@@](C[n]3nnnc3)(c(c(F)c3)ccc3F)O)(F)F)cc2)cc1 Chemical compound N#Cc1ccc(COC(C=C2)=CC=CC2C#Cc2cnc(C([C@@](C[n]3nnnc3)(c(c(F)c3)ccc3F)O)(F)F)cc2)cc1 LBBHRBLMMYBWEM-VGFJAJBZSA-N 0.000 description 1
- JFHOATHDSUPBNY-SSEXGKCCSA-N N#Cc1ccc(COc(cc2)ccc2C#Cc2cnc(C([C@@H](c(c(F)c3)ccc3F)/[O]=C/[n]3nnnc3)(F)F)cc2)cc1 Chemical compound N#Cc1ccc(COc(cc2)ccc2C#Cc2cnc(C([C@@H](c(c(F)c3)ccc3F)/[O]=C/[n]3nnnc3)(F)F)cc2)cc1 JFHOATHDSUPBNY-SSEXGKCCSA-N 0.000 description 1
- UDGASIIGNCBLSI-SSEXGKCCSA-N N#Cc1ccc(COc(cc2)ccc2C#Cc2cnc(C([C@@](C[n]3nnnc3)(c(c(F)c3)ccc3F)O)(F)F)cc2)cc1 Chemical compound N#Cc1ccc(COc(cc2)ccc2C#Cc2cnc(C([C@@](C[n]3nnnc3)(c(c(F)c3)ccc3F)O)(F)F)cc2)cc1 UDGASIIGNCBLSI-SSEXGKCCSA-N 0.000 description 1
- RKDYIOGHCIESBV-MUUNZHRXSA-N N#Cc1ccc(COc(cc2)ccc2C#Cc2cnc(C([C@H](C[n]3nnnc3)c(ccc(F)c3)c3F)(F)F)cc2)cc1 Chemical compound N#Cc1ccc(COc(cc2)ccc2C#Cc2cnc(C([C@H](C[n]3nnnc3)c(ccc(F)c3)c3F)(F)F)cc2)cc1 RKDYIOGHCIESBV-MUUNZHRXSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562220384P | 2015-09-18 | 2015-09-18 | |
| US62/220,384 | 2015-09-18 | ||
| US201662275504P | 2016-01-06 | 2016-01-06 | |
| US62/275,504 | 2016-01-06 | ||
| PCT/US2016/052151 WO2017049096A1 (en) | 2015-09-18 | 2016-09-16 | Antifungal compound process |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018527367A JP2018527367A (ja) | 2018-09-20 |
| JP2018527367A5 true JP2018527367A5 (show.php) | 2019-07-25 |
| JP6887993B2 JP6887993B2 (ja) | 2021-06-16 |
Family
ID=58289604
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018513603A Pending JP2018532719A (ja) | 2015-09-18 | 2016-09-16 | 抗真菌化合物および作製方法 |
| JP2018513579A Expired - Fee Related JP6887993B2 (ja) | 2015-09-18 | 2016-09-16 | 抗真菌化合物調製方法 |
| JP2018514436A Active JP6847458B2 (ja) | 2015-09-18 | 2016-09-16 | 抗真菌化合物のプロセス |
| JP2021083727A Pending JP2021121606A (ja) | 2015-09-18 | 2021-05-18 | 抗真菌化合物および作製方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018513603A Pending JP2018532719A (ja) | 2015-09-18 | 2016-09-16 | 抗真菌化合物および作製方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018514436A Active JP6847458B2 (ja) | 2015-09-18 | 2016-09-16 | 抗真菌化合物のプロセス |
| JP2021083727A Pending JP2021121606A (ja) | 2015-09-18 | 2021-05-18 | 抗真菌化合物および作製方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US10464921B2 (show.php) |
| EP (3) | EP3349586B1 (show.php) |
| JP (4) | JP2018532719A (show.php) |
| KR (3) | KR20180052755A (show.php) |
| CN (3) | CN108289457B (show.php) |
| AU (3) | AU2016323782B2 (show.php) |
| BR (2) | BR112018005194B1 (show.php) |
| CA (3) | CA2998805C (show.php) |
| EA (3) | EA037521B1 (show.php) |
| ES (2) | ES2821021T3 (show.php) |
| HK (3) | HK1258862A1 (show.php) |
| HU (1) | HUE053638T2 (show.php) |
| MX (3) | MX2018003284A (show.php) |
| PL (1) | PL3349586T3 (show.php) |
| TW (3) | TWI730986B (show.php) |
| WO (3) | WO2017049096A1 (show.php) |
| ZA (1) | ZA201801404B (show.php) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015143192A1 (en) * | 2014-03-19 | 2015-09-24 | Viamet Pharmaceuticals, Inc. | 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation |
| CA2942968C (en) | 2014-03-19 | 2022-03-15 | William J. Hoekstra | Antifungal compound process |
| CA2942972A1 (en) | 2014-03-19 | 2015-09-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Antifungal compound process |
| AU2015231220B2 (en) | 2014-03-19 | 2019-04-04 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Antifungal compound process |
| JP6613391B2 (ja) | 2014-03-19 | 2019-12-04 | ブイピーエス‐３，インコーポレイテッド | ２−（２，４−ジフルオロフェニル）−１，１−ジフルオロ−１−（５−置換ピリジン−２−イル）−３−（１ｈ−テトラゾール−１−イル）プロパン−２−オールおよびその調製工程 |
| AU2015231275B2 (en) | 2014-03-19 | 2019-03-07 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| WO2015143162A1 (en) | 2014-03-19 | 2015-09-24 | Viamet Pharmaceuticals, Inc. | Antifungal compound process |
| EP3119771B1 (en) | 2014-03-19 | 2020-05-06 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| AU2015231238B2 (en) | 2014-03-19 | 2019-04-04 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| WO2017049096A1 (en) | 2015-09-18 | 2017-03-23 | Viamet Pharmaceuticals, Inc. | Antifungal compound process |
| CN109666019B (zh) * | 2017-10-14 | 2021-04-06 | 朱允涛 | 一种氘代的氮唑醇类化合物及其制备方法和用途 |
| EP3710432A1 (en) | 2017-11-13 | 2020-09-23 | Bayer Aktiengesellschaft | Tetrazolylpropyl derivatives and their use as fungicides |
| WO2021188404A1 (en) * | 2020-03-19 | 2021-09-23 | Assia Chemical Industries Ltd | Solid state forms of oteseconazole and process for preparation thereof |
| CA3226998A1 (en) * | 2021-07-22 | 2023-01-26 | Mycovia Pharmaceuticals, Inc. | Compositions comprising oteseconazole |
| CN114573557B (zh) * | 2022-03-28 | 2024-03-08 | 浙江天宇药业股份有限公司 | 一种奥特康唑的制备方法 |
| CN114573503B (zh) * | 2022-03-28 | 2024-04-09 | 浙江天宇药业股份有限公司 | 一种制备奥特康唑中间体的方法 |
| CN116621816B (zh) * | 2022-09-23 | 2025-07-04 | 北京莱瑞森医药科技有限公司 | 一种伏立康唑对映异构对b的拆分方法 |
| TW202423418A (zh) * | 2022-09-30 | 2024-06-16 | 大陸商上海濟煜醫藥科技有限公司 | 雙環類化合物的無定形、結晶固體及其製備方法 |
| CN119798219B (zh) * | 2025-01-13 | 2025-07-18 | 长治医学院 | 一种奥特康唑的制备方法 |
Family Cites Families (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2854015B2 (de) | 1978-12-14 | 1980-10-09 | Dynamit Nobel Ag, 5210 Troisdorf | Verfahren zur Herstellung von !H-TetrazoI-1-essigsauren und bestimmter Ester derselben |
| EP0069442B1 (en) | 1981-06-06 | 1985-02-20 | Pfizer Limited | Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them |
| CS228931B2 (cs) | 1981-06-06 | 1984-05-14 | Pfizer | Způsob výroby 2-(2,4-difluorfenyl)-l,3-bis(lH-l,2,4-triazol-l-yl)propan- -2-oiu |
| GB8304282D0 (en) | 1983-02-16 | 1983-03-23 | Pfizer Ltd | Antifungal agents |
| US4921475A (en) | 1983-08-18 | 1990-05-01 | Drug Delivery Systems Inc. | Transdermal drug patch with microtubes |
| US5087240A (en) | 1983-08-18 | 1992-02-11 | Drug Delivery Systems Inc. | Transdermal drug patch with conductive fibers |
| US5163899A (en) | 1987-03-20 | 1992-11-17 | Drug Delivery Systems Inc. | Transdermal drug delivery system |
| US5312325A (en) | 1987-05-28 | 1994-05-17 | Drug Delivery Systems Inc | Pulsating transdermal drug delivery system |
| GB8804164D0 (en) | 1988-02-23 | 1988-03-23 | Tucker J M | Bandage for administering physiologically active compound |
| US5008110A (en) | 1988-11-10 | 1991-04-16 | The Procter & Gamble Company | Storage-stable transdermal patch |
| US5088977A (en) | 1988-12-21 | 1992-02-18 | Drug Delivery Systems Inc. | Electrical transdermal drug applicator with counteractor and method of drug delivery |
| ATE107176T1 (de) | 1989-12-04 | 1994-07-15 | Searle & Co | System zur transdermalen albuterol applikation. |
| US5352456A (en) | 1991-10-10 | 1994-10-04 | Cygnus Therapeutic Systems | Device for administering drug transdermally which provides an initial pulse of drug |
| JPH07502219A (ja) | 1991-12-18 | 1995-03-09 | ミネソタ マイニング アンド マニュファクチャリング カンパニー | 多重層型バリアー構造体 |
| ATE132381T1 (de) | 1992-01-29 | 1996-01-15 | Voelkl Franz Ski | Ballspielschläger, insbesondere tennisschläger |
| JP2000344744A (ja) | 1999-06-04 | 2000-12-12 | Ss Pharmaceut Co Ltd | アセトフェノン誘導体およびその製法 |
| JP2005505841A (ja) * | 2001-10-08 | 2005-02-24 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 動き推定のための装置及び方法 |
| JP2004359646A (ja) | 2003-06-09 | 2004-12-24 | Ss Pharmaceut Co Ltd | 抗真菌活性を有する新規アゾール誘導体 |
| US7241800B2 (en) | 2004-03-17 | 2007-07-10 | Mai De Ltd. | Anhydrous amorphous form of fluvastatin sodium |
| US8198448B2 (en) | 2006-07-14 | 2012-06-12 | Amgen Inc. | Fused heterocyclic derivatives and methods of use |
| KR100889937B1 (ko) | 2007-08-06 | 2009-03-20 | 한미약품 주식회사 | 보리코나졸의 제조방법 |
| UA108596C2 (xx) | 2007-11-09 | 2015-05-25 | Інгібітори пептиддеформілази | |
| KR101109215B1 (ko) | 2009-06-17 | 2012-01-30 | 보령제약 주식회사 | 보리코나졸의 신규 중간체 및 이를 이용한 보리코나졸의 제조방법 |
| CN102803232A (zh) | 2009-06-18 | 2012-11-28 | 巴斯夫欧洲公司 | 杀真菌的具有5-硫取代基的1,2,4-三唑衍生物 |
| HUE026474T2 (en) | 2010-04-24 | 2016-06-28 | Viamet Pharmaceuticals Inc | Metalloenzyme inhibitor compounds |
| PH12013502624A1 (en) | 2011-06-19 | 2014-02-17 | Viamet Pharmaceuticals Inc | Metalloenzyme inhibitor compounds |
| EP3067350B1 (en) | 2011-06-19 | 2018-06-13 | Viamet Pharmaceuticals (NC), Inc. | Metalloenzyme inhibitor compounds |
| KR101964195B1 (ko) | 2011-06-23 | 2019-04-01 | 비아멧 파마슈티컬즈(엔씨), 인코포레이티드 | 금속효소 억제제 화합물 |
| TW201329025A (zh) | 2011-11-01 | 2013-07-16 | Astex Therapeutics Ltd | 醫藥化合物 |
| KR102070345B1 (ko) * | 2011-12-11 | 2020-01-28 | 마이코비아 파마슈티컬즈, 인코포레이티드 | 금속효소 억제제 화합물 |
| WO2013109998A1 (en) | 2012-01-20 | 2013-07-25 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| CA2861341A1 (en) | 2012-01-20 | 2013-07-25 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds against fungal infection induced plant diseases and method of use thereof |
| NZ713828A (en) * | 2012-06-04 | 2017-05-26 | Pharmacyclics Llc | Crystalline forms of a bruton’s tyrosine kinase inhibitor |
| KR20140012226A (ko) * | 2012-07-18 | 2014-02-03 | 엘지전자 주식회사 | 태양전지 모듈 |
| EP2894981B1 (en) | 2012-09-12 | 2019-12-04 | Dow AgroSciences LLC | Metalloenzyme inhibitor compounds |
| WO2014117090A1 (en) | 2013-01-28 | 2014-07-31 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| WO2014165861A1 (en) | 2013-04-05 | 2014-10-09 | The Regents Of The University Of California | Metal-catalyzed coupling of aryl and vinyl halides with alpha, alpha-difluorocarbonyl compounds |
| HK1223093A1 (zh) | 2013-05-28 | 2017-07-21 | Viamet Pharmaceuticals (NC), Inc. | 杀真菌组合物 |
| US9688671B2 (en) | 2013-06-12 | 2017-06-27 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| AU2015231275B2 (en) | 2014-03-19 | 2019-03-07 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| CA2942972A1 (en) | 2014-03-19 | 2015-09-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Antifungal compound process |
| WO2015143192A1 (en) | 2014-03-19 | 2015-09-24 | Viamet Pharmaceuticals, Inc. | 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation |
| WO2015143162A1 (en) | 2014-03-19 | 2015-09-24 | Viamet Pharmaceuticals, Inc. | Antifungal compound process |
| AU2015231238B2 (en) | 2014-03-19 | 2019-04-04 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| AU2015231220B2 (en) | 2014-03-19 | 2019-04-04 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Antifungal compound process |
| CA2942968C (en) * | 2014-03-19 | 2022-03-15 | William J. Hoekstra | Antifungal compound process |
| JP6613391B2 (ja) | 2014-03-19 | 2019-12-04 | ブイピーエス‐３，インコーポレイテッド | ２−（２，４−ジフルオロフェニル）−１，１−ジフルオロ−１−（５−置換ピリジン−２−イル）−３−（１ｈ−テトラゾール−１−イル）プロパン−２−オールおよびその調製工程 |
| US9802914B2 (en) | 2014-03-19 | 2017-10-31 | Viamet Pharmaceuticals, Inc. | Antifungal compound process |
| EP3119771B1 (en) * | 2014-03-19 | 2020-05-06 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| MX381344B (es) | 2015-03-19 | 2025-03-12 | Mycovia Pharmaceuticals Inc | Compuestos antifungicos y procesos para la fabricacion. |
| MX378499B (es) | 2015-05-18 | 2025-03-11 | Mycovia Pharmaceuticals Inc | Compuestos antifungicos. |
| WO2017049096A1 (en) | 2015-09-18 | 2017-03-23 | Viamet Pharmaceuticals, Inc. | Antifungal compound process |
| US10513506B2 (en) | 2015-11-17 | 2019-12-24 | Dow Agrosciences Llc | 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)pyridin-3-yl and processes of preparation |
| EP3377475A4 (en) | 2015-11-17 | 2019-04-10 | Dow Agrosciences Llc | 4 - ((6-2- (2,4-difluorophenyl) -1,1-difluoro-2-hydroxy-3- (1H-1,2,4-triazol-1-YL) PROPYL) PYRIDINE-3-YL ) OXY) BENZONITRIL AND METHOD OF PREPARING THEREOF |
| BR112018009924A2 (pt) | 2015-11-17 | 2018-11-13 | Dow Agrosciences Llc | 4-((6-(2-(2,4-difluorfenil)-1,1-diflúor-2-oxoetil)piridin-3-il)óxi)benzonitrila e processos de preparação |
| WO2017087592A1 (en) | 2015-11-17 | 2017-05-26 | Viamet Pharmaceuticals, Inc. | 4-((6-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation |
| WO2017117393A1 (en) | 2015-12-30 | 2017-07-06 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
-
2016
- 2016-09-16 WO PCT/US2016/052151 patent/WO2017049096A1/en not_active Ceased
- 2016-09-16 AU AU2016323782A patent/AU2016323782B2/en not_active Ceased
- 2016-09-16 AU AU2016324148A patent/AU2016324148B2/en not_active Ceased
- 2016-09-16 ES ES16847394T patent/ES2821021T3/es active Active
- 2016-09-16 MX MX2018003284A patent/MX2018003284A/es unknown
- 2016-09-16 US US15/760,738 patent/US10464921B2/en active Active
- 2016-09-16 EP EP16847379.1A patent/EP3349586B1/en active Active
- 2016-09-16 JP JP2018513603A patent/JP2018532719A/ja active Pending
- 2016-09-16 PL PL16847379T patent/PL3349586T3/pl unknown
- 2016-09-16 HK HK19101334.2A patent/HK1258862A1/zh unknown
- 2016-09-16 MX MX2018003280A patent/MX391539B/es unknown
- 2016-09-16 WO PCT/US2016/052128 patent/WO2017049080A1/en not_active Ceased
- 2016-09-16 KR KR1020187010879A patent/KR20180052755A/ko not_active Ceased
- 2016-09-16 BR BR112018005194-2A patent/BR112018005194B1/pt not_active IP Right Cessation
- 2016-09-16 EP EP16847394.0A patent/EP3349587B1/en active Active
- 2016-09-16 EA EA201890751A patent/EA037521B1/ru not_active IP Right Cessation
- 2016-09-16 AU AU2016323767A patent/AU2016323767B2/en active Active
- 2016-09-16 ES ES16847379T patent/ES2858314T3/es active Active
- 2016-09-16 CN CN201680061980.3A patent/CN108289457B/zh active Active
- 2016-09-16 BR BR112018005198-5A patent/BR112018005198A2/pt not_active Application Discontinuation
- 2016-09-16 HK HK18115458.3A patent/HK1263287A1/zh unknown
- 2016-09-16 EP EP16847471.6A patent/EP3349753A4/en not_active Withdrawn
- 2016-09-16 JP JP2018513579A patent/JP6887993B2/ja not_active Expired - Fee Related
- 2016-09-16 CA CA2998805A patent/CA2998805C/en active Active
- 2016-09-16 WO PCT/US2016/052300 patent/WO2017049196A1/en not_active Ceased
- 2016-09-16 MX MX2018003357A patent/MX391538B/es unknown
- 2016-09-16 KR KR1020187010880A patent/KR102798709B1/ko active Active
- 2016-09-16 CA CA2998808A patent/CA2998808A1/en active Pending
- 2016-09-16 HU HUE16847379A patent/HUE053638T2/hu unknown
- 2016-09-16 HK HK19101335.1A patent/HK1258863A1/zh unknown
- 2016-09-16 CA CA2998807A patent/CA2998807A1/en active Pending
- 2016-09-16 US US15/760,917 patent/US10308632B2/en active Active
- 2016-09-16 EA EA201890752A patent/EA036098B1/ru not_active IP Right Cessation
- 2016-09-16 JP JP2018514436A patent/JP6847458B2/ja active Active
- 2016-09-16 US US15/760,812 patent/US10513505B2/en active Active
- 2016-09-16 KR KR1020187010867A patent/KR20180053393A/ko not_active Ceased
- 2016-09-16 CN CN201680066541.1A patent/CN108347949B/zh not_active Expired - Fee Related
- 2016-09-16 CN CN201680066558.7A patent/CN108348511A/zh active Pending
- 2016-09-16 EA EA201890522A patent/EA038214B1/ru unknown
- 2016-09-19 TW TW105130167A patent/TWI730986B/zh not_active IP Right Cessation
- 2016-09-19 TW TW105130165A patent/TWI766842B/zh not_active IP Right Cessation
- 2016-09-19 TW TW105130166A patent/TWI723047B/zh active
-
2018
- 2018-02-28 ZA ZA2018/01404A patent/ZA201801404B/en unknown
-
2019
- 2019-07-01 US US16/458,252 patent/US10836740B2/en active Active
-
2021
- 2021-05-18 JP JP2021083727A patent/JP2021121606A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018527367A5 (show.php) | ||
| JP2018529687A5 (show.php) | ||
| JP2022043078A5 (show.php) | ||
| JP2009543861A5 (show.php) | ||
| JP2019048806A5 (show.php) | ||
| JP2010180243A5 (show.php) | ||
| TW200817335A (en) | Process for preparing 3-dihalomethylpyrazole-4-carboxylic acid derivatives | |
| JP2014503001A5 (show.php) | ||
| JP2013227568A5 (show.php) | ||
| JP2020073474A5 (show.php) | ||
| WO2014128139A1 (en) | Process for the preparation of enantiomerically enriched 3-aminopiperidine | |
| JP2013100237A5 (show.php) | ||
| JP2009062360A (ja) | シナカルセットの製造方法 | |
| JP2009062360A6 (ja) | シナカルセットの製造方法 | |
| JP2014516968A5 (show.php) | ||
| JP2020502077A5 (show.php) | ||
| CN101857559A (zh) | 手性α-(三氯甲基)胺类化合物及其制备方法 | |
| JP6251197B2 (ja) | 置換フェニルプロパノンを調製するためのプロセス | |
| JP2018115129A5 (show.php) | ||
| KR101744046B1 (ko) | 실로도신 합성에 유용한 중간체의 제조방법 | |
| JP2014196365A5 (show.php) | ||
| JP2012524736A5 (show.php) | ||
| JP2011513358A5 (show.php) | ||
| RU2015147242A (ru) | Способ получения арформотерола или его соли | |
| JP5673169B2 (ja) | ４級アンモニウム塩及びそれを用いたシクロプロパン化合物の製造方法 |